Brazil Guidance on Drug Tracking Calls for Real-Time Reporting

Drugmakers operating in Brazil must report all supply chain movements to regulatory authorities in real time, according a new guidance on the country’s drug tracking and tracing system. But an attorney familiar with the topic says the system doesn’t address concerns of biosimilars.
Drug GMP Report